Directors' Report
Dear Members,
The Board of Directors is pleased to present the Twentieth Annual Report of Bajaj
Consumer Care Limited ("BCCL" or "the Company") for the financial
year ended March 31, 2026.
In compliance with the applicable provisions of the Companies Act, 2013 ("the
Act") and the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), this
report covers the financial results and other developments during the financial year from
April 1, 2025 to March 31,2026.
Financial Performance
The summarised Standalone financial results of the Company for the Financial Year ended
March 31,2026 are presented below:
|
|
(Rs. in Lakh) |
Particulars |
Financial year ended March 31,2026 |
Financial year ended March 31,2025 |
| Total Income |
111,779.90 |
97,829.27 |
| Profit before interest, depreciation and tax |
25,103.72 |
16,796.91 |
| Finance cost |
159.03 |
53.72 |
| Depreciation |
1,464.70 |
974.16 |
| Profit before tax |
23,479.99 |
15,769.03 |
| Provision for taxation - Income Tax |
4,106.93 |
2,755.16 |
| Profit after tax |
19,373.06 |
13,013.87 |
| Other comprehensive income |
19.84 |
(102.64) |
| Total comprehensive income |
19,392.90 |
12,911.23 |
| Balance brought forward from previous year |
70,905.79 |
58,622.69 |
| Retained earnings available for appropriation |
71,343.22 |
70,905.79 |
| Appropriations - |
|
|
| - Dividend/Interim dividend |
- |
- |
| Balance carried to balance sheet |
71,343.22 |
70,905.79 |
Du11ng the period under review, the Company recorded total revenue of INR 1 1 1,779.90
lakh as compared to 97,829.27 lakh in the previous year. Profit before Tax was INR
23,4-79.99 lakh as against INR 15,769.03 lakh in the previous year. The Profit after Tax
stood at INR 19,373.06 lakh as compared to the Profit after Tax of INR 13,013.87 lakh in
the previous year. The opera t ions and financial results of the Company a re elaborated
in the Management Discussion and Analysis Report.
Material changes and commitments
There are no rnatei lal changes & commitments which affects the financial position
of the Company between the end of financial year 2025-26 and the date of this report.
Further, there is no change in the nature of business of the Company.
Transfer to Reserves
Your Directors do not propose to transfer any amount to Reserves.
Dividend Distribution Policy
Your Company's dividend distribution philosophy aims to appropriately reward
shareholders through distribution of profits while ensuring sufficient funds are retained
for growth and strategic initiatives. Pursuant to Regulation 43A of the SEBI Listing
Regulations, the Company has formulated a Dividend Distribution Policy, which sets out the
parameters and circumstances to be considered by the Board while declaring dividends. The
said Policy is available on the Company's website and can be accessed using the link:
https://www.baiaiconsurnercare.corn/policies.php
Dividend
The Board of Dnectors has not recommended any dividend for the financial year under
review.
Share Capital
The paid-up EquityShare Capitalof the Company as on March 31, 2026 was Rs. 13,06,18,321
divided into 13,06,18,321 equity shares of Re. 1/- each as against Rs. 13,70,52,803
divided into 13,70,52,803 equity shares of Re. 1/- each as on March 31, 2025.
During the year under review, the company has extinguished 64-,34-,4-82 equity shares
pursuant to the buyback approved by the Board of Directors at its meeting held on July 24,
2025 and the shareholders vide postal ballot, result of which was declared on August 29,
2025.
Buyback of equity shares
The Board of Directors of the Company, at its meeting held on July 2k, 2025,
approved the buyback of up to 64,34,482 (Sixty Four Lakh Thirty Four Thousand Four Hundred
Eighty Two) Equity Shares, representing 4.69% of the total number of Equity Shares in the
paid-up equity share capital of the Company as at March 31, 2025, from the shareholders/
beneficial owners of Equity Shares as on the Record Date, i.e., Friday, September 5, 2025,
on a proportionate basis through the "tender offer" process, in accordance with
the SEBI (Buy- Back of Securities) Regulations, 2018, at a price of INR 290/- (Indian
Rupees Two Hundred and Ninety only) per Equity Share, payable in cash, for an aggregate
maximum amount of INR 18,660 Lakh (Indian Rupees Eighteen Thousand Six Hundred and Sixty
Lakh only) ("Buyback Offer Size").
The Buyback Offer Size excludes transaction costs. The Buyback Offer Size represented
23.70% and 24.88% of the aggregate of the Company's fully paid-up equity share capital and
free reserves as per the audited standalone and consolidated financial statements of the
Company for the financial year ended March 31, 2025, respectively, being the latest
audited financial statements available as on the date of the Board meeting approving the
Buyback.
The Company adopted the tender offer route for the purpose of the Buyback. The Buyback
was implemented through the "Mechanism for acquisition of shares through Stock
Exchange" in accordance with the applicable provisions of the SEBI (Buy-Back of
Securities) Regulations, 2018 and the relevant circulars issued by the Securities and
Exchange Board of India ("SEBI"), including Circular No. CIR/CFD/
POLICYCELL/1/2015 dated April 13, 2015, Circular No. CFD/ DCR2/CIR/P/2016/131 dated
December 9, 2016, and Circular No. SEBI/HO/CFD/DCR-lll/CIR/P/2021/615 dated August 13,
2021, as amended from time to time, and such other circulars or notifications as may be
applicable.
The Buyback opened on Thursday September 1 1, 2025 and closed on Wednesday September
17, 2025.
Pursuant to the Buyback, 64,34,482 (Sixty-Four Lakh Thirty- Four Thousand Four Hundred
Eighty-Two) Equity Shares were bought back at a price of INR 290/- (Indian Rupees Two
Hundred and Ninety only) per Equity Share.
The total amount utilised for the Buyback was INR 18,660 Lakh (Indian Rupees Eighteen
Thousand Six Hundred and Sixty Lakh only), excluding transaction costs.
Acquisition of Vishal Personal Care Limited
The Board of Directors of the Company, at its meeting held on February 14, 2025,
approved the execution of a Share Purchase-cum-Shareholders' Agreement ("SPSHA")
with Peepul Capital Fund III LLC, Vishal Personal Care Private Limited ("Target
Company") and other parties, for the acquisition of 100% of the equity share capital
of the Target Company in two tranches, comprising 49% (forty-nine percent) in the first
tranche and the remaining 51% (fifty-one percent) in the second tranche.
The Company acquired 49% of the equity share capital in the first tranche, pursuant to
which the Target Company became an Associate Company of the Company with effect from March
10, 2025. During the current financial year, the Company acquired the remaining 51% of the
equity share capital, and consequently, Vishal Personal Care Private Limited became a
wholly owned subsidiary of the Company with effect from May 16, 2025.
Demerger
During May 2025, the Company completed the acquisition of the remaining 51% stake in
Vishal Personal Care Limited ("VPCL"), consequent to which VPCL became a wholly
owned subsidiary of the Company.
VPCL operates through two distinct segments, namely: (i) Manufacturing and Distribution
of Consumer Products, comprising the manufacture, distribution and sale of products across
skin care, body care and hair care categories; and (ii) Trademark Licensing and Other
Business. These segments have distinct risk-return profiles, operational dynamics and
growth drivers.
In line with the Company's strategy to enhance operational efficiency and create
long-term value, the Board of Directors, at its meeting held on July 24, 2025, approved a
Scheme of Demerger for the transfer of the Manufacturing and Distribution business of VPCL
to Bajaj Consumer Care Limited ("BCCL" or the "Company").
The proposed demerger is expected to, inter alia, enable sharper business focus, drive
operational synergies, improve resource utilization and result in cost efficiencies. It is
also expected to enhance the Company's market reach, strengthen cash flows and create
greater value for stakeholders.
The Scheme of Arrangement between VPCL and BCCL, under Sections 230 to 232 of the
Companies Act, 2013, provides for the transfer of the Manufacturing and Distribution
undertaking of VPCL to the Company on a going concern basis, with an appointed date of
March 15, 2025 (or such other date as may be approved by the Hon'ble National Company Law
Tribunal ("NCLT").
The Scheme has received approval from the Hon'ble NCLT, Jaipur. Upon the Scheme
becoming effective, all assets, liabilities, employees, contracts and other business
elements pertaining to the said undertaking shall stand transferred to and vested in the
Company.
The transaction will be accounted for in accordance with applicable accounting
standards using the pooling of interest method, with assets and liabilities recorded at
their existing book values.
The residual business of VPCL, primarily relating to trademark licensing and allied
activities, will continue to remain with VPCL. As VPCL is a wholly owned subsidiary, the
Scheme does not involve any issuance of shares or cash consideration.
Employee Restricted Stock Unit Plan 2018
The Members of the Company, at the Annual General Meeting held on July 23, 2018,
approved the Employee Restricted Stock Unit Plan, 2018 ("RSU 2018"), authorising
the grant of not more than 7,37,500 restricted stock units to eligible employees, in one
or more tranches, with each unit conferring a i ight to apply for one Equity Share of the
Company, subject to the terms and conditions of the Plan.
The disclosures as required under the SEBI (Share Based Employee Benefits and Sweat
Equity) Regulations, 2021 are annexed to this Report as Annexure-1 and are also
available on the website of the Company at https://www. baiaiconsurnercare.corn/policies.
Particulars of Loans, Guarantees and Investments
Details of loans, guarantees and investments covered undei the provisions of Section
186 of the Companies Act, 2013 are provided in the Notes to the Financial Statements
forming part of this Annual Report.
Subsidiaries and Associate Companies
As on March 31,2026, the Company had the following unlisted subsidiaries/associate
namely:
Uptown Properties and Leasing Private Limited
Bajaj Bangladesh Limited (wholly owned subsidiary)
Bajaj Corp International (FZE) (wholly owned subsidiary)
Vishal Personal Care Limited (wholly owned subsidiary)
Out of the above subsidiaries, Uptown Properties and Leasing Private Limited is a
"Material Subsidiary" in terms of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015. The Policy for Determining Material Subsidiaries, as
approved by the Board, is available on the website of the Company at
https://www.baiaiconsurnercare. com/policies.php.
Pursuant to the provisions of Section 129 of the Act read with the Companies (Accounts)
Rules, 2014, a separate statement containing the salient features of the financial
statements of the Company's subsidiaries, in the prescribed Form AOC- 1, is attached to
the financial statements forming part of this Annual Report.
Subsidiaries Operations
Uptown Properties and Leasing Private Limited (Uptown)
During the Financial Year ended March 31, 2026, the net Loss of Uptown was INR 24.84
lakh as against net loss of INR 26.24 lakh of the previous Financial Year.
The Company is into the business of construction and leasing of commercial space.
Bajaj Bangladesh Limited (BBL)
During the financial year ended March31,2026, BBL achieved total revenue of INR
1,495.56 lakh in FY 2025-26 as compared to INR 1426.31 lakh in previous financial year.
Net loss for the current FY 2025-26 was at INR 13.52 lakh as against net loss of INR
224.68 lakh of the previous financial year.
Bajaj Corp International (FZE)
Dunng the financial year ended March 31, 2026, FZE achieved total revenue of
INR1,562.71 lakh as compared to INR 1,800.92 lakh of the previous financial year. Net Loss
for the current FY 2025-26 was INR 336.59 lakh as against net loss of INR 291.36 lakh of
the previous financial year.
Vishal Personal Care Limited (VPCL)
VPCL became a fully owned subsidiary of BCCL with effect from 16 May 2025. Thereafter
VPCL achieved total revenue of INR 5,118.96 lakh. Net loss for the penod was I NR 38.96
lakh. Consequently, the financial performance for FY 2025-26 is not comparable with that
of the previous financial year. The other details have been provided in AOC-1.
Consolidated Financial Statements
The Consolidated Financial Statements of the Company have been prepared in accordance
with the applicable Indian Accounting Standards prescribed bythe Ministry of Corporate
Affairs and form part of this Annual Report.
In accordance with Section 136 of the Act, the audited standalone and consolidated
financial statements of the Company, together with the audited financial statements of
each of its subsidiaries and all other documents required to be attached thereto, are
available on the website of the Company at
https://www.baiaiconsurnercare.corn/financial-result.
These documents are also available for inspection by the Members at the Registered
Office of the Company during business hours on all working days, except Saturdays, Sundays
and National HoLidays, up to the date of the 20th Annual General Meeting
("AGM").
Management Discussion and Analysis Report
The Management Discussion and Analysis Report is presented in a separate section
forming part of this Annual Report.
Corporate Social Responsibility (CSR) Initiatives
In accordance with the requirements of the provisions of Section 135 of the Act, the
Company has constituted a CSR Committee. The Company has also formulated a CSR Policy
which is available on Company's website at https://www.
baiaiconsurnercare.com/policies.php.
During the year under review, in compliance with the provisions of Section 135 of the
Act, the Companies (Corporate Social Responsibility) Rules, 20U and the various
notifications/ circulars issued bythe Ministry of Corporate Affairs, the Company has spent
Rs. 345.70 lakh on permitted CSR activities through Kamalnayan Jarnnalal Bajaj Foundation
(the implementing agency engaged in activities specified in Schedule VII of the Act).
Detailed information on CSR policy, its salient features, CSR initiatives undertaken
during the year, details pertaining to spent amount are given in Annexure-2 to this
Directors' Report.
Business Risk Management
The Company, like any other enterprise, is exposed to various business risks, both
internal and external in nature. One of the key i isks faced in the current business
environment is the wide and frequent fluctuation in the prices of raw materials. Any
significant increase in raw material costs may exert pressure on the Company's operating
margins.
Further, inflationary trends in the economy and adverse macroeconomic developments may
impact consumer spending power. This could lead to down-trading from branded to
non-branded products, which may, in turn, affect the Company's operating performance.
The Company operates in a highly competitive FMCG market, where competitors may possess
greater financial strength to invest aggressively in advertising and marketing, as well as
greater flexibility to respond swiftly to changing economic and business conditions. An
increase in competitive intensity may have a material adverse impact on the Company's
market share and sales performance.
Additionally, any unexpected changes in the regulatory framework, including those
relating to fiscal benefits and other related matters, may affect the Company's operations
and profitability.
A key determinant of the Company's ability to create sustainable value lies in
itscapacityandwillingnessto identify, assume, and manage risks effectively and
efficiently. The Company remains fully cognizant of the aforementioned risks and, as part
of its business strategy has established appropriate mechanisms to mitigate them through
timely and proactive action.
The Company has implemented a robust Business Risk Management (BRM) framework designed
to identify and evaluate business risks and opportunities. The framework aims to enhance
transparency minimise potential adverse impacts on business objectives, and strengthen the
Company's competitive advantage. The details of the Risk Management Policy are available
on the Company's website at https://www.baiaiconsumercare.com/policies.
In the opinion of the Board of Directors, none of the above- mentioned risks threaten
the existence of the Company.
Vigil Mechanism/ Whistle-Blower Policy & Code of Conduct
The Company has adopted a Whistle-Blower Policy for Du ectors, employees and business
partners to report genuine concerns, unethical behaviour, actual or suspected fraud, or
violations of the Company's Code of Conduct.
The mechanism provides for adequate safeguards against victimisation of persons who
avail of the facility and ensures direct access to the Chairperson of the Audit Committee
in appropi late or exceptional cases. The Company affirms that no personnel have been
denied access to the Audit Committee.
The detailed framework and functioning of the Vigil Mechanism are elaborately described
in the Corporate Governance Report forming part of this Annual Report. The Whistle-Blower
Policy is available on the Company's website at
https://www.baiaiconsurnercare.corn/policies.
Further, the Company's Code of Conduct reinforces its commitment to ethical business
practices and integrity. The Code clearly defines the standards of behaviour expected from
Directors and employees and outlines the processes for addressing and resolving any
breaches thereof.
Remuneration Policy
Pursuant to the provisions of Section 178 of the Act and Regulation 19 of the SEBI
Listing Regulations, the Board of Directors, on the recommendation of the Nomination,
Remuneration and Corporate Governance Committee, has formulated and adopted a Nomination
and Remuneration Policy.
The Policy lays down the criteria for appointment, reappointment and removal of
Directors, Key Managerial Personnel and Senior Management personnel. It also sets out the
framework for remuneration, performance evaluation, and succession planning. Further, the
Policy includes the criteria for determining qualifications, positive attributes,
independence of Directors and other matters as prescribed under Section 178(3) of the Act
and applicable SEBI Listing Regulations.
The Committee is also entrusted with the responsibility of developing and recommending
to the Board a set of Corporate Governance Guidelines to strengthen governance practices
within the Company.
The Nomination and Remuneration Policy is available on the Company's website at at
https:www.baiaiconsurnercare. com/policies.php.
The salient features of the Nomination and Remuneration Policy are as follows:
To identify individuals who are qualified to become Directors and members of
Senior Management, in accordance with the criteria approved by the Board, and to
periodically review the structure, composition,
functioning and performance of the Board, its Committees and Senior Management, and
recommend changes, as considered necessary;
To recommend to the Board the appointment of new Directors in the event of
resignation of existing Directors or pursuant to a planned expansion of the Board;
To recommend to the Board the composition of various Committees of the Board;
To formulate the criteria for evaluation of the Board and Independent Directors;
To determine the criteria for qualifications, positive attributes and
independence of Directors;
To recommend to the Board a remuneration policy for Directors, Key Managerial
Personnel and other employees;
To develop and recommend to the Board a set of Corporate Governance Guidelines;
To oversee the performance evaluation of the Board, its Committees and the
Management;
To review the Company's policies and processes in key areas of Corporate
Governance, other than those specifically assigned to other Board Committees, with a view
to ensuring adherence to best governance practices;
To examine the impact of significant regulatory and statutory changes affecting
the governance practices of the Company and recommend appropriate measures for
implementation;
To regularly review and strengthen the Company's organisational health by
improving the hiring, retention, motivation, development, deployment and conduct of
management and other employees.
In this context, the Committee also reviews the framework and processes for motivating
and rewarding performance at all levels of the organisation. It evaluates the compensation
structure and recommends to the Board all forms of remuneration payable to Directors, Key
ManagerialPersonnel, Senor Management and other employees of the Company.
Board of Directors Appointment & Cessation
Pursuant to the provisions of Section 161(1) of the Act and the Articles of Association
of the Company the Board of Directors, based on the recommendation of the Nomination,
Remuneration and Corporate Governance Committee, at its meeting held on May 5, 2025,
approved the re-appointment of Mr. Surmt Malhotra (DIN: 02183825) as a Non-Executive,
Non-Independent Director of the Company for a term of five (5) years with effect from July
1, 2025, subject to the approval of the Members at the ensuing Annual General Meeting.
Further, the Members of the Company at the 19th Annual General Meeting held on August 1
1, 2025, approved the reappointment of Mr. Surmt Malhotra as a Non-Executive, Non-
Independent Director of the Company for a penod of five (5) years with effect from July 1,
2025.
Retirement by Rotation
In accordance with the provisions of Section 152 and other applicable provisions, if
any, of the Act, not less than two- thiids of the total number of Directors, excluding
Independent Directors, are liable to retire by rotation. One-third of these Directors are
requii ed to retire at every Annual General Meeting and, being eligible, may offer
themselves for re-appointrnent.
At the ensuing Annual General Meeting ("AGM"), Mr. Kushagra Bajaj (DIN:
00017575), Director of the Company, retires by rotation and being eligible, has offered
himself for re-appointment.
A bi lef profile of Mr. Kushagra Bajaj along with the additional disclosures required
pursuant to Regulation 36(3) of the SEB Listing Regulations and the applicable Secretarial
Standards on General Meetings, is provided in the Annexure to the Notice convening the
AGM.
The Board of Directors recommends his re-appointment for the approval of the Members at
the ensuing AGM.
Number of Meetings of the Board
The Board of Directors met six (6) tunes during the financial year 2025-26 on May 5,
2025, June 24, 2025, July 24, 2025, August 11, 2025, November 10, 2025 and January 21,
2026. The maximum interval between any two meetings aid not exceed one hundred and twenty
(120) days, as prescribed under Regulation 17 of the SEBI Listing Regulations, Section 173
of the Act and the Secretarial Standard on Meetings of the Board of Directors.
Annual evaluation by the Board
Pursuant to the applicable provisions of the Act and the SEBI Listing Regulations, the
Board of Directors carried out an annual evaluation of its own performance, the
performance of its committees and that of individual Directors, including the Chairman of
the Board.
The Nomination, Remuneration & Corporate Governance Committee has defined the
criter la forevaluation of the Board, its Committees and Directors. The evaluation was
conducted through a structured questionnane prepared separately foi the Board, Committees,
Chanman and individual Directors, covering various aspects of performance and
effectiveness.
The Board's performance was evaluated on parameters including, inter alia, degree of
fulfilment of key responsibilities, Board structure and composition, establishment and
effective functioning of Committees, delineation of roles and responsibilities,
effectiveness of Board processes, quality and timeliness of information flow and overall
governance oversight.
The performance of individual Directors was evaluated on parameters such as attendance
and active participation in Board and Committee Meetings, contribution to discussions and
decisionmaking, guidance and support to management, professional qualifications,
experience, knowledge and competency, independence of judgment, integrity, adherence to
the Company's Code of Conduct and, in case of Independent Directors, compliance with the
Code for Independent Directors preserved under the Act.
The Chairman was evaluated, inter alia, on leadership qualities, setting the
strategicagenda of the Board, promoting open and constructive discussions, encouraging
active participation by all Directors and ensuring effective decisionmaking processes.
The Committees of the Board were assessed on the degree of fulfilment of their key
responsibilities, adequacy of composition, effectiveness of meetings and compliance with
applicable statutory requirements.
In a separate meeting of Independent Directors, performance of the Chairman and
Non-Independent Directors was evaluated, and the Independent Directors also reviewed the
performance of the Board as a whole. The performance evaluation of Independent Directors
was carried out by the entire Board, excluding the Director being evaluated.
The Directors expressed satisfaction with the evaluation process and its outcomes.
The detailed policy on evaluation of the Board's performance is available on the
Company's website at https://www. baiaiconsumercare.com/policies.php.
Familiarisation Programme for Independent Directors
Pursuant to the provisions of Regulation 25 of the SEBI Listing Regulations, the
Company has formulated a
programme for familiarising the Independent Directors with their roles, rights, and
responsibilities within the Company, as well as the nature of the industry in which the
Company operates, through various initiatives. The details of the aforesaid programme are
available on the Company's website at https://www.bajajconsumercare.com/investors-
farniliai ization-proaramme.
Board Committees
A. Audit Committee
The current composition of the Audit Committee comprises the following members:
1. Mr. Jagdish Acharya [Independent Director],
Chairman of the Committee
2. Mr. Anupam Dutta, [Independent Director] Member
3. Mr. K. S. Narayanan, [Independent Director] Member
A. Ms. Lilian Jessie Paul [Independent
Director], Membei
B. Nomination, Remuneration & Corporate
Governance Committee
The current composition of the Nomination, Remuneration & Corporate Governance
Committee comprises the following members:
1. Mr. Jagdish Acharya [Independent Director],
Chairman of the Committee
2. Mr. Anuparn Dutta [Independent Director], Member
3. Ms. Lilian Jessie Paul [Independent
Director], Member
C. Stakeholders Relationship Committee
The current composition of the Stakeholders Relationship Committee comprises the
following members:
1. Mr. K. S. Narayanan [Independent Director], Chairman of the Committee
2. Mr. Kushagra Nayan Bajaj [Non-Executive, Non- ndependent Director], Member
3. Mr. Naveen Pandey [Non-Independent, Executive Director], Member
A. Mr. Surnit Malhotra [Non-Executive, Non- ndependent Director], Member
5. Mr. Virnal Chandra Nagori [Non-Executive, Non- ndependent Director], Member
D. Corporate Social Responsibility (CSR) Committee
The current composition of the Corporate Social Responsibility Committee comprises the
following members:
1. Mr. Jagdish Acharya [Independent Director],
Chairman of the Committee
2. Mr. Naveen Pandey [Non-Independent, Executive
Director], Member
3. Mr. Surnit Malhotra [Non-Executive, Non-
Independent Director], Member
A. Mr. Virnal Chandra Nagori [Non-Executive, Non- Independent Director], Member
E. Risk Management & ESG Committee
The current composition of the Risk Management & ESG
Committee comprises the following members:
1. Mr. Anupam Dutta [Independent Director],
Chairman of the Committee
2. Mr. Naveen Pandey [Non-Independent, Executive Director], Member
3. Ms. Lilian Jessie Paul [Independent, Non-Executive Director], Member
A. Mr. Rajesh Menon [Head-Supply Chain, Operations and IT], Member
F. Buyback Committee
The current composition of the Buyback Committee comprises the following members:
1. Mr. Kushagra Bajaj [Non-Executive, Non- ndependent Director], Chairman
2. Mr. Naveen Pandey [Non-Independent, Executive Director], Member
3. Mr Virnal Chandra Nagori [Non-Executive, Non- ndependent Director], Member
Directors and Key Managerial Personnel (KMP)
Mr. Naveen Pandey (DIN: 0958A377) was appointed as Managing Director of the Company
w.e.f. July 01, 2025 for a period of five consecutive years till June 30, 2030 pursuant to
retirement of Mr. Jaideep Nandi (DIN: 06938A80) as Managing Director w.e.f. June 30, 2025
upon completion of his term of five years. The board comprises the following Directors as
on March 31,2026:
Mr. Kushagra Bajaj, Non-Executive Chairman
Mr. Naveen Pandey, Managing Director
Mr. Sumit Malhotra, Non-Executive, Non-Independent
Mr. Vimal Chandra Nagori, Non-Executive, Non-Independent
Mr. Jagdish Acharya, Non-Executive, Independent
Mr. Anupam Dutta, Non-Executive, Independent
Mr. K. S. Narayanan, Non-Executive, Independent
Ms. Lilian Jessie Paul, Non-Executive, Independent
In terms of the provisions of Section 203 of the Companies Act, 2013, following are the
KMPs of the Company:
Mr. Naveen Pandey, Managing Director
Mr. D. K. Maloo, Chief Financial Officer
Mr. Vivek Mishra, Head-Legal & Company Secretary
Declaration by Independent Directors
The Independent Directors of the Company have submitted declaration of Independence
confirming that they meet the criteria of independence under Section 14-9(6) of the Act
and SEBI Listing Regulations.
All the Independent Directors of the Company have also confirmed that they are not
aware of any circumstance or situation, which exist or may be reasonably anticipated, that
could impair or impact their ability to discharge their duties with an objective
independent judgement and without any external influence and that they are independent of
the management. Further, it is also confirmed that they have complied with the provisions
regarding Independent Dnectors' registration with the databank maintained by The Indian
Institute of Corporate Affairs ('MCA') and online proficiency self-assessrnent test
conducted by the IICA unless exempted.
The Board is of the opinion that the Independent Directors of the Company possess
requisite qualifications, experience and expertise and they hold highest standards of
integrity.
Directors' Responsibility Statement
To the best of then knowledge and belief and according to the information and
explanations obtained by them, your Directors make the following statements in terms of
Section 134(5) of the Act:
(a) that in the preparation of the annual financial statements for the year ended March
31, 2026, the applicable accounting standards have been followed along with pro per exp la
nation relating to rnatei ia l departures, if any;
(b) that such accounting policies as mentioned in the Notes to the Financial Statements
have been selected and applied consistently and judgement and estimates have been made
that are reasonable and prudent so as to give a true and fair view of the state of affairs
of the Company as at March 31,2026 and of the profit of the Company for the year ended on
that date;
(c) that proper and sufficient care has been taken for the maintenance of adequate
accounting records in accordance with the provisions of the Companies Act, 2013 for
safeguarding the assets of the Company and for preventing and detecting fraud and other
irregularities;
(d) that the annual financial statements have been prepared on a going concern basis;
(e) that proper internal financial controls were in place and that the financial
controls were adequate and were operating effectively;
(f) that systems to ensure compliance with the provisions of all applicable laws were
in place and were adequate and operating effectively.
Related Party Transactions
The Board of Directors has adopted a Policy on Related Party Transactions. The Policy
is available on the Company's website at https://www.baiaiconsumercare.com/policies.php.
The Policy sets out the mechanism for identification, review, approval, disclosure and
reporting of related party transactions in compliance with applicable laws and regulatory
requn ements.
During the Financial Year under review, all contracts/ arrangements/transactions
entered into or modified with related parties were in the ordinary course of business and
on an arm's length basis. All such transactions were placed before the Audit Committee for
prior approval, except those covered under omnibus approval granted in accordance with
applicable provisions of the Act and SEBI LODR.
No material related party transactions were entered into during the Financial Year.
Further, the Company has not entered into any transaction of a material nature with its
Promoters, subsidiaries of Promoters, Directors, Key Managerial Personnel or their
relatives that may have a potential conflict with the interests of the Company.
Accordingly, the disclosure of related party transactions in Form AOC-2, as required
under Section 134(3)(h) of the Act
read with Rule 8(2) of the Companies (Accounts) Rules, 2014-, is not applicable for the
Financial Year under review.
Details of related party transactions, as required under the applicable accounting
standards, form part of the notes to the financial statements included in this Annual
Report.
Internal Financial Controls
The Company has established an internal financial control system commensurate with the
size, scale and complexity of its operations, and such controls are operating effectively.
The internal financial control framework has been designed considering the nature of
activities carried out at various locations and across business operations. These controls
provide reasonable assurance with regard to the orderly and efficient conduct of business,
adherence to the Company's policies, safeguarding of assets, prevention and detection of
frauds and errors, and the accuracy and completeness of accounting records, including the
timely preparation of reliable financial information.
The Internal Auditor periodically evaluates the adequacy and effectiveness of the
internal control systems, accounting procedures and policies adopted by the Company. Based
on the internal audit reports, the respective process owners undertake necessary
corrective actions to strengthen the control environment.
Significant audit observations and the status of corrective actions thereon are placed
before the Audit Committee of the Board for its review and oversight.
Auditors
(a) Statutory Auditors
The Members of the Company at the 16th Annual General Meeting ("AGM") held on
August 1, 2022 approved the appointment of M/s. Chopra Virnal & Co., Chartered
Accountants (Firm Registration No. 06456C), as the Statutory Auditors of the Company for a
term of five consecutive years, to hold office from the conclusion of the 16th AGM until
the conclusion of the 21st AGM of the Company.
M/s. Chopra Virnal & Co. have confirmed that they are within the limits prescribed
under Section 14-1 (3)(g) of the Act and are not disqualified from being appointed as
Statutory Auditors in terms of Sections 139 and U1 of the Act read with the Companies
(Audit and Auditors) Rules, 20U.
As required under Regulation 33(1 )(d) of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations 2015, the Statutory Auditors have confirmed that they hold a
valid certificate issued by the Peer Review Board of the Institute of Chartered
Accountants of India ("ICAI").
The Report of the Statutory Auditors on the financial statements for the Financial Year
under review does not contain any qualification, reservation, adverse remark or
disclaimer. The observations, if any, contained in the Auditor's Report read together with
the notes to the financial statements are self-explanatory and therefore do not call for
any further explanation pursuant to Section 134-(3)(f) of the Act.
During the Financial Year under review, the Statutory Auditors have not reported any
instance of fraud under Section 143(12) of the Act. Accordingly, no details are required
to be disclosed under Section 134(3)(c) (a) of the Act.
(b) Secretarial Auditor
Pursuant to the provisions of Section 204 of the Act read with Rule 9 of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014, and Regulation 24A of
the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI
LODR"), the Members of the Company have approved the appointment of Mr. Hitesh J.
Gupta, Practicing Company Secretary (Firm Registration No. I2013MH1 107800), as the
Secretarial Auditor of the Company for a term of five (5) consecutive financial years
commencing from April 1, 2025 up to March 31, 2030 to conduct the Secretarial Audit of the
Company.
The Secretarial Audit Report for the Financial Year under review, issued by the
Secretarial Auditor, does not contain any qualification, reservation, adverse remark or
disclaimer and is annexed herewith as Annexure - 3 to this Director's Report.
Cost Audit
The Ministry of Corporate Affairs, vide its Notification dated December 31, 2014,
amended the Companies (Cost Records and Audit) Rules, 2014 through the Companies (Cost
Records and Audit) Amendment Rules, 2014.
In terms of the said Amendment Rules and considering the nature of the Company's
business activities, the Company is not required to maintain cost records orto have its
cost records
audited for the Financial Year under review. Accordingly, the requirement of Cost Audit
is not applicable to the Company.
Reporting of Frauds
There was no instance of fraud during the year under review, which required the
Statutory Auditors to report to the Audit Committee and/ or Board under Section 14-3(12)
of the Act and Rules made thereunder.
Corporate Governance Report and Certificate
In compliance with Regulation 34 read with Schedule V(C) of SEBI Listing Regulations, a
report on Corporate Governance and the certificate as required under Schedule V(E) of SEBI
Listing Regulations received from the Statutory Auditors of the Company, forms part of
this Annual Report.
Compliance of Corporate Governance Standards of New York Stock Exchange (NYSE)
The Company, to achieve greater transparency and to comply with internationally
prevalent norms of Corporate Governance, has voluntarily adopted Corporate Governance
Standards codified in Section 303A of New York Stock Exchange (NYSE) Listed Company
Manual. The details of the same and the steps taken by the Company are explained in the
Corporate Governance Report.
Compliance of Secretarial Standards of ICSI
In terms of Section 118(10) of the Act, the Company is complying with the applicable
Secretanal Standards issued by the Institute of Company Secretaries of India and approved
by Central Government.
Business Responsibility and Sustainability Report
In compliance with SEBI Listing Regulations, Business Responsibility and Sustainability
Report detailing the vai ious initiatives taken by the Company on environmental,
socialand governance front is forming a part of this Annual Report. The Board of Directors
has adopted a Business Responsibility Policy which is available on Company's website at
https:// www.baiaiconsurnercare.com/policies.php.
Energy Conservation, Technology Absorption and Foreign Exchange Earnings and Outgo
The disclosure of particulars with respect to Conservation of Energy, Technology
Absorption and Foreign Exchange
Earnings and Outgo as requ ned under Sect ion 134(3)(rn) of the read with Rule 8(3) of
the Companies (Accounts) Rules, 20U is annexed herewith as Annexure-4 to this
Diiectors' Repoi t.
Annual Return
The Annual Return as provided under Section 92(3) of the Act and as prescribed in Form
No. MGT-7 of the Companies (Management and Administration) Rules, 20U, is available on the
website of the Company at httpsY/bajajconsurnercare.
corn/qeneral-meetinqsmostalballots-aqm.php.
Disclosure under the Sexual Harassment of Women at Workplace (Prevention, Prohibition
and Redressal) Act, 2013
The Company has in place a policy for prevention of sexual harassment at the workplace
in line with the requirements of Sexual Flarassrnent of Women at Workplace (Prevention,
Prohibition and Redressal) Act, 2013. An Internal complaints committee has been set up to
redress complaints, if any received regarding sexual harassment at workplace.
The following is the summary of sexual harassment complaints received and disposed off
during the year under review.
1. Number of Complaints received: 1
2. Number of Complaints disposed off: 1.
Particulars of Employees
The disclosures pertaining to remuneration and other details as required under Section
197(12) of the Act read with Rule 5(1) of the Companies (Appointment and Remuneration of
Managerial Personnel) Rules, 2014. are provided in Annexure-5 forming part of this
Directors' Repoi t.
In accordance with the first proviso to Section 136(1) of the Act, the Directors'
Report is being cnculated to the Members excluding the statement containing particulars of
employees as required under Section 197(12) of the Act read with Rule 5 of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014. The said statement is
available for inspection by the Members at the Registered Office of the Company during
business hours on all working days, except Saturdays, Sundays and National Flolidays, up
to the date of the 20th Annual General Meeting (AGM).
Any Member interested in obtaining a copy of the said statement or inspecting the same
may write to the Company Secretary in advance.
Further, it is hereby coi Firmed that the Managing Director of the Company does not
receive any remuneration or commission from the Company's holding and/or subsidiary
companies.
Listing Agreement
In compliance with SEBI Circular No. CIR/CFD/CMD/6/2015 dated October 13, 2015, the
Company has executed a Uniform Listing Agreement with BSE Limited and National Stock
Exchange of India Limited, where Equity Shares of the Company are listed. Company has paid
annual listing fees to both the Stock Exchanges.
Prohibition of Insider Trading
In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company
has adopted a 'Code of Conduct for Regulating, Monitoring and Reporting of Trading by
Insiders and 'Code of Fair Disclosure' of Unpublished Price Sensitive Information to
ensure prohibition of Insider Trading in the Organisation. The said codes are available on
Company's website at https://www.baiajconsumercare. corn/pol i cies.php.
The 'Trading Window' is closed when the Compliance Officer determines that a designated
person or class of designated persons can reasonably be expected to have possession of
Unpublished Price Sensitive Information. The Company Secretary of the Company has been
designated as Compliance Officer to administer the Code of Conduct and other requirements
under SEBI (Prohibition of Insider Trading) Regulations, 2015.
General Disclosure
During the year under review:
a) the Company has not issued Equity Shares with differential rights as to dividend,
voting or otherwise, pursuant to the provisions of Section A3 of Act and Rules made
thereunder.
b) the Company has not made any provisions of money or has not provided any loan to its
employees for purchase of shares of the Company or its holding Company, pursuant to the
provisions of Section 67 of Act and Rules made thereunder.
c) the Company has not accepted any deposit from the public, pursuant to the Chapter V
of the Act and Rules made thereunder
d) there are no significant material orders passed by the Regulators/Courts which would
impact the going concern status of the Company and its future operations.
e) there was no occasion where the Board has not accepted any recommendation of the
Audit Committee.
f) no application was filed for corporate insolvency resolution process, by a financial
or operational creditoi or by the Company itself under the IBC before the NCLT.
Industrial Relations
Industrial relations have been cordial at all the manufacturing units of the Company.
Cautionary Statement
Statements contained in the Directors' Report and the Management Discussion and
Analysis Report describing the Company's objectives, expectations, estimates or
predictions may constitute "forward-looking statements" within the meaning of
applicable securities laws and regulations.
Actual results may differ materially from those expressed or implied in such statements
due to various risks and uncertainties. Important factors that could influence the
Company's operations and performance include, but are not limited to, global and domestic
demand and supply conditions affecting selling prices, capacity additions, availability
and cost of critical raw materials, changes in government policies and tax laws, economic
conditions and development within the country, and other factors material to the Company's
business operations.
Acknowledgements
Your directors express their appreciation for the sincere cooperation and assistance of
Central and State Government authorities, bankers, customers, suppliers and business
associates. Your directors also wish to place on record their deep sense of appreciation
for the committed services by your Company's employees. Your directors acknowledge with
gratitude, the encouragement and support extended by our valued shareholders.
|
For and on behalf of the Board of Directors |
|
Kushagra Nayan Bajaj |
| Place: Murnba |
Chairman |
| Date: April 17, 2026 |
(DIN :00017575) |